|

Sorafenib Clinical Trials

13 actively recruiting trials across 3 locations

Also known as: BAY-43-9006, Nexavar, Nexavar(R), Nexavar, BAY43-9006, sorafenib tosylate, sorafinib

Other10 trials

Clinical Pharmacogenetic Study of Sorafenib in Egyptian Patients With Hepatocellular Carcinoma
Phase 1/2
Clinical Study of Induction Therapy Options Based on Molecular Subtyping and MRD in Children and Adolescents With AML
Phase 2
Combination of Toripalimab and JS004 Therapy for ccRCC
Phase 2
Combined HAIC, TKI/Anti-VEGF and ICIs as Conversion Therapy for Unresectable Hepatocellular Carcinoma
Combined TACE, TKI/Anti-VEGF and ICIs as Conversion Therapy for Advanced Hepatocellular Carcinoma
Efficacy of Organoid-Based Drug Screening to Guide Treatment for Locally Advanced Thyroid Cancer
Phase 2
Immune Checkpoint Therapy vs Target Therapy in Reducing Serum HBsAg Levels in Patients With HBsAg+ Advanced Stage HCC
Phase 2
SNF Platform Study of HR+/ HER2-advanced Breast Cancer
Phase 2
Sorafenib Relapase Prophylaxis After HCT With PTBCy Regimen
Phase 2
Treateament of Newly Diagnosed Acute Monocytic Leukemia in Children
Phase 2/3

Birmingham, Alabama1 trial

Pediatric Precision Laboratory Advanced Neuroblastoma Therapy

University of Alabama/Children's of Alabama

Phase 2

Gainesville, Florida1 trial

AD HOC Trial: Artificial Intelligence-Based Drug Dosing In Hepatocellular Carcinoma

University of Florida

Phase 2

Memphis, Tennessee1 trial

Safety and Efficacy of Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor Patients

St. Jude Children's Research Hospital

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.